Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

830 projects found matching your search criteria :

  1. Theranostic oxygen nanobubbles for cancer radiotherapy enhancement and perfusion imaging

    Call: OPUS 23 , Panel: NZ4

    Principal investigator: dr hab. Martyna Elas

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  2. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  3. Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Zuzanna Maria Nowicka-Kaszkowiak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  4. Highly-internalizing intrinsically fluorescent oligomeric cytotoxic conjugate targeting breast cancer cells overproducin...

    Call: PRELUDIUM 21 , Panel: NZ1

    Principal investigator: dr Natalia Porębska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  5. The role of MTARC2 protein-related metabolism changes in the intestinal tumorigenesis

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Michał Marek Mikula

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  6. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne...

    Call: PRELUDIUM 21 , Panel: NZ1

    Principal investigator: Katarzyna Joanna Dziubek

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

  7. Sensitive detection and visualization of cancer biomarkers using upconversion nanoparticles excited above 1000 nm

    Call: PRELUDIUM 21 , Panel: ST4

    Principal investigator: dr Natalia Maria Jurga

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  8. Local and systemic Tryptophan metabolites as gastric cancer biomarkers

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Kinga Ożga

    Katolicki Uniwersytet Lubelski Jana Pawła II

  9. ECbiome genotyping and assessment of its involvement in pathogenic processes of endometrial cancer development

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Aleksandra Maria Kowalczyk

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  10. Polycyclic aromatic hydrocarbons as potential factors disrupting the functions of the ovary and promoting the developmen...

    Call: SONATA 17 , Panel: NZ9

    Principal investigator: dr Anna Paulina Kozubek

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Hodowli i Biologii Zwierząt

  11. The role of 5-methylcytosine RNA methyltransferases in the regulation of cancer cell responses to extracellular and exog...

    Call: OPUS 22 , Panel: NZ2

    Principal investigator: dr hab. Anna Karolina Lewińska

    Uniwersytet Rzeszowski, Collegium Medicum Wydział Biotechnologii

  12. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Collegium Medicum

  13. Combinatorial targeting of non-genetic sources of cell-to-cell heterogeneity to overcome fractional killing of cancer ce...

    Call: SONATA 17 , Panel: NZ3

    Principal investigator: dr Jarosław Walczak

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  14. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

  15. New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  16. The triangle: carotenoids-retinoids-cytochromes plays a key role in development and progress of cancer

    Call: OPUS 22 , Panel: ST4

    Principal investigator: prof. Halina Abramczyk

    Politechnika Łódzka

  17. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

  18. Adaptation of mitochondrial functions to stress caused by plastic dust/pollution; action of mitochondrial retrograde sig...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Joanna Bogumiła Szczepanowska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  19. In vitro tracing of cellular senescence to cancer stem cell formation using a nanoparticle-based reporter system

    Call: OPUS 22 , Panel: NZ3

    Principal investigator: dr Patrick McDevitt Perrigue

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

  20. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  21. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  22. Targeting cell surface proteoglycans with high affinity multimeric ligands and their cytotoxic conjugates – towards prec...

    Call: OPUS 22 , Panel: NZ1

    Principal investigator: dr hab. Łukasz Opaliński

    Uniwersytet Wrocławski, Wydział Biotechnologii

  23. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr hab. Natalia Vydra

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  24. Identification and therapeutic targeting of the mRNA splicing alteration mechanisms driven by gain-of-function TP53 muta...

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Magdalena Oroń

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  25. Identification of the adipogenic niche derived molecules as the factors driving the colorectal cancer cell progression

    Call: OPUS 22 , Panel: NZ3

    Principal investigator: dr hab. Dorota Nowak

    Uniwersytet Wrocławski, Wydział Biotechnologii

  26. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

  27. Epigenetic regulation of estrogen receptor beta driven response in colon cancer.

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Agnieszka Anna Rawłuszko-Wieczorek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  28. FGFR2-->JunB axis in progression of ER+ breast cancer - molecular analyses and prognostication

    Call: PRELUDIUM BIS 3 , Panel: NZ3

    Principal investigator: dr hab. Rafał Sebastian Sądej

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  29. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com...

    Call: SONATA BIS 11 , Panel: NZ5

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  30. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  31. Biotinylated boronic acid derivative as a tool for targetable detection of oxidants in cancer cells

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Przemysław Adam Siarkiewicz

    Politechnika Łódzka, Wydział Chemiczny

  32. Analysis of volatile organic compounds in selected human bodily fluids and tissues as potential markers of gastric cance...

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Daria Dominika Ślefarska-Wolak

    Uniwersytet Jana Kochanowskiego w Kielcach, Wydział Nauk Ścisłych i Przyrodniczych

  33. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Natalia Anna Maciejewska

    Politechnika Gdańska

  34. Evolutionary genomics: Modeling and prediction of progression of breast and lung cancer

    Call: OPUS 21 , Panel: NZ2

    Principal investigator: prof. Marek Kimmel

    Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

  35. Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in pro...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: prof. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  36. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Szymon Tomczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  37. New bioanalytical microsystem for modeling culture of gynecological cancers.

    Call: OPUS 21 , Panel: ST4

    Principal investigator: dr hab. Elżbieta Jastrzębska

    Politechnika Warszawska, Wydział Chemiczny

  38. Collagen-hyaluronic gels as an environment for a controlled change of mechanical properties of spheroids under shear for...

    Call: OPUS 21 , Panel: ST5

    Principal investigator: prof. Małgorzata Barbara Lekka

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  39. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

  40. Classification and detection of 3D DBT volumes to aid radiologists in breast cancer screening

    Call: PRELUDIUM 20 , Panel: ST6

    Principal investigator: Jakub Piotr Chłędowski

    Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

  41. Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: dr Joanna Elżbieta Kałafut

    Uniwersytet Medyczny w Lublinie

  42. Estrogenic mycotoxins (ZEA, α-ZOL) and tumor progression - an in vitro model of obesity and breast cancer

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: dr Kinga Anna Urbanek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  43. Breast cancer metastasis-induced endothelial-mesenchymal transition alongside ageing; implications for therapy

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Marta Maria Smęda

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  44. Spatial gene expression analysis of FFPE breast cancer undercovers potential of well-preserved samples to identify regul...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: Adrian Janusz Perdyan

    Gdański Uniwersytet Medyczny

  45. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  46. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Shaoshan Mai

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  47. Thrombin binding aptamer with expanded chemical diversity as potential anticoagulant and anticancer agent

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Weronika Paulina Kotkowiak

    Instytut Chemii Bioorganicznej PAN

  48. Extracellular vesicles carrying microRNA in experimental immunotherapy for glioblastoma

    Call: OPUS 21 , Panel: NZ6

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  49. MLK4 signaling in DNA damage response and cancer therapy

    Call: PRELUDIUM 20 , Panel: NZ3

    Principal investigator: Dawid Grzegorz Mehlich

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  50. Mechanisms of generation of myeloid-derived suppressor cells of monocyte origin (Mo-MDSCs) by extracellular vesicles fro...

    Call: PRELUDIUM 20 , Panel: NZ6

    Principal investigator: dr Izabela Siemińska

    Uniwersytet Jagielloński, Collegium Medicum

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy